1.gif (1892 bytes)

Brief Reports

Indian Pediatrics 2001; 38: 267-271  

Seropositivity Rate for HIV Infection in Hospitalized Children on Selective Screening


Mukesh Agrawal
G.V. Koppikar*
Radha Ghildiyal
Mrinalini Chavarkar
Surekha M. Joshi
Keya R. Lahiri

From the Departments of Pediatrics and Microbiology*, T.N. Medical College and B.Y.L. Nair Hospital, Mumbai, India.

Correspondence to: Dr. Mukesh Agrawal, Building 1, Flat 11, Haji Ali Govt. Colony, K.R. Khadye Marg, Mumbai 400 034, India.

Manuscript received: December 1, 1999;
Initial review completed: January 7, 2000;
Revision accepted: August 29, 2000

Though the first seropositive infant was detected as early as in 1987(1), in India children are usually considered at the periphery of Acquired Immunodeficiency Syndrome (AIDS) pandemic. However, despite frequent under-reporting, 4% of total AIDS cases in India till 1996 were below 14 years of age(2).

In Mumbai, a city with the highest prevalence of adult Human Immuno-deficiency Virus (HIV) infection in India, around 2.5% to 4.2% of antenatal mothers were found to be seropositive recently(3,4). The study hospital is located near a large commercial sex area, where nearly half of the workers are infected(3,4).

The present analysis was conducted to detect the seropositive rate (SPR) for HIV infection in hospitalized children, and to assess the usefulness of screening on the grounds of clinical suspicion in detection of new cases.

  Subject and Methods

The present study includes prospectively collected data in two phase (1992-1994 and 1997-1998) and information obtained on review of case records for the years 1995-1996. During this period, hospitalized children of pediatric wards who had history of high risk exposure and/or clinical features suggestive of symptomatic HIV infection(5) were screened for HIV infection, using an ELISA test (Innogenetics, Belgium or Labsystem OY, Finland).

Many cases fulfilling these criteria could not be screened due to refusal of consent or shortage of diagnostic kits. Newborns born to seropositive mothers in our hospital were also excluded.

All ELISA reactive cases, were subjected to a second ELISA or a rapid test (HIV- Spot; Genelabs diagnostics, Geneva or Immunocomb II; Organics, Israel) as Western blot testing was not feasible in many of them due to financial constraints. As per World Health Organization (WHO), a combination of ELISA and/or simple rapid test may be used for the surveillance in developing countries(6).

All children above 18 months with double test positive were considered ‘seropositive’. However, younger children were labeled as seropositive only if they also fulfilled the WHO criteria for symptomatic HIV infection(7), as viral confirmatory tests were not possible in the study set up.

Seropositive children were further classi-fied as per Center for Disease control (CDC) case definition(8). and seropositive children of less than 18 months, who didn’t fulfill CDC definition were considered as perinatally exposed.

 Results

A total of 821 children, i.e., 5.5% of 14990 admissions during study period were screened. Of them, 124 were found sero-positive, with an overall seropositivity rate (SPR) of 0.83% among all screened cases. Western blot test could be done in 23 cases, and was positive in all of them.

SPR among hospitalized cases increased from 0.21% in 1992 to 1.49% in 1998, rise being more marked during 1997-98. Number of cases screened also increased gradually and nearly doubled in 1998. Throughout the study period, 9.8% to 19.0% of screened cases were found seropositive (Table 1).

Table I - Yearwise Distribution of Study Data Related to Seropositive Cases Among all Hospitalized/Screened Cases

Year  Total admissions Total screened No. (%) Seropositive cases SPR/THC (%) SPR/TSC (%) 
1992  1875  23 (1.2)  0.21  17.4
1993  1716  76 (4.4)  13  0.76 17.1
1994  1857  87 (4.7)  10  0.54  11.5
1995   2190*  102 (4.7)  10  0.46  9.8
1996  2402  160 (4.7)  19  0.79  11.9
1997  2368  195 (8.2)  37  1.56 19.0
1998  2082  178 (8.5)  31  1.49  17.4
Total  14990  821 (5.5)  124  0.83  15.1

SPR/THC: Seropositivity rate among total hospitalized cases.
SPR/TSC : Serpositivity rate among total screened cases.
Figures in parantheses indicate percentage of cases screened out of total admissions.
* Total admissions increased from 1995 onwards due to addition of a new unit.

Ninety one per cent children were initially screened on clinical suspicion, of whom 11.9% were seropositive. However, in most of them mothers were found seropositive on retrograde testing. In comparison, half of the 68 cases tested for high risk history were seropositive. Overall, 72.6% serospositive cases in this study were investigated on the clinical grounds alone, before their high risk status was known.

While 46.8% of seropositive cases were below 18 months of age, 17.8% children were more than five years old at the time of diagnosis. A distinct male preponderance was noted, more apparent in older children (Table II).

Table II - Age and Sex Wise Distribution of Seropositive Cases
Age group  (Yrs)  Males  Females Total No (%)
< 1.5  33 25  58 (46.8)*
1.5 - 3.0  20  11  31 (25.0)
3.1 - 5.0  13 (10.5)
5.1 - 7.0  11 (8.9)
>7.0  11 (8.9)
Total  77  47  124
(62.1%)  (37.9%)

* Including 31 infants.
Male : Female ratio :: 1.6:1 (<1.5 yrs 1.3 : 1, 1.5-5.0 yrs 1.6 : 1, >5yrs 3.4 : 1)

In 103 cases, mothers were either seropositive or had died of AIDS (4 cases). Of these, 21 (20.4%) were known commercial sex workers (CSW). Another 11 cases were also probably perinatally infected, though their mothers could not be tested. Among the six cases of the transfusion related infection (3 nutritional anemia, 2 hemolytic anemia, 1 idiopathic thrombocytopenic purpura), five were diagnosed before 1994. All had received transfusion at peripheral hospitals or nursing homes, five of them getting after 1988, when blood screening became mandatory. Two street boys aged 5 and 7 years had history of probable sexual abuse. In 2 cases, source could not be identified.

Eighty two (66.1%) seropositive cases fulfilled CDC criteria(8). Forty-two cases of under 18 months were considered as ‘perinatally exposed’, though all of them fulfilled WHO criteria for symptomatic HIV infection(7).

 Discussion

HIV infected children are usually identified at the entry points of infection, i.e., by screening of babies born to seropositive mothers or recipients of blood transfusions. Review of literature reveals sparsity of surveillance studies for HIV infection in clinically suspected children.

Emodi and Okafur from Nigeria reported 23% seropositivity among children with clinically suspected HIV infection, during 1989-96(9). Recently, Merchant and Shroff from Mumbai reported 24% and 18% sero-positivity in children with chronic diarrhea or disseminated tuberculosis, respectively(10). Their findings as well as 15.1% seropositivity seen in present study indicate that pediatric HIV infection is an emerging reality in Mumbai. However, it is to be noted that the study hospital is in a high risk locality and our observations may not be representative.

Rising SPR among hospitalized children seen in this study, is perhaps a result of marked rise in seroprevalence among ante-natal mothers. However partly, this rise may also be due to more liberal screening due to increased awareness and easier availability of diagnostic facilities.

Higher positivity among screened cases, seen in recent years, further indicates rising prevalence of infection. But it is also possible that as clinicians become familiar with clinical presentation, they may become more selective in ordering screening thereby improving yield of the screening tests. Lower SPR during 1995-96 was probably due to retrospective data collection for this period, when screening criteria might not have been stringent.

Though the SPR in cases screened on the clinical grounds alone was much lower than in cases with high risk factors, it is noteworthy that nearly three-fourths of the seropositive cases were taken up for initial screening on clinical suspicion alone. Obviously, clinical suspicion based screening appears an effective strategy for detection of new cases, though may not be as rewarding as high risk approach.

In this study, 46.8% cases were less than eighteen months old. Confirmation of infection in this age group is a problem in developing countries, due to non-affordability of confirmatory tests. Application of CDC criteria(8) for clinical diagnosis is also difficult, as it requires sophisticated labo-ratory support. WHO criteria for clinical diagnosis of symptomatic HIV infection(7) appear to be a more practical alternative in these resource poor settings. All younger cases in this study who failed to meet stricter CDC criteria and were categorized as peri-natally exposed, fulfilled WHO case defini-tion. This observation indicates that even these perinatally exposed cases were also most likely infected.

Male preponderance in the present study may be due to gender bias in self referral to the hospital. However, the sex ratio became more discriminatory in older age groups, being 1.3 : 1 in less than 18 months old cases as compared to 3.4 : 1 in children above 5 years of age. Whether this difference was merely due to more obvious gender bias in older children or also due to differences in clinical progression of the disease in two sexes is not clear.

With stricter transfusion regulations, horizontal spread of HIV in children is becoming exceedingly uncommon. Rarity of transfusion related cases in this study may also be due to the fact that most of the thalassemics in this hospital are treated in the hematology rather than the pediatric depart-ment. In the study hospital, SPR among frequently transfused children is around 5% (personal communication). The fact that cases of transfusion related infection are still seen, despite mandatory screening, indicate either problems of compliance or fallibility of screening tests. As most of these cases have history of transfusions at peripheral health care centers, monitoring of transfusion practices, specially in these set-ups, need to be strengthened.

To conclude, the present study indicates rising seroprevalence of pediatric HIV infection in India and suggests screening on clinical suspicion as an additional pick up point for detection of new cases along with high risk screening programs.

Contributors : MA conceptualised, co-ordinated and analyzed the study as well as drafted the paper; he will act as guarantor for the paper. GVK, a microbiologist conducted ELISA/rapid tests and contributed in interpretation of data. RG and MC participated in data collection and analysis. SMJ and KRL participated in data interpretation as well as critical review of the contents during drafting of the paper.

Funding: None.
Competing interests:
None stated.

Key Messages

  • Pediatric HIV infection is an emerging reality in the study population.
  • Clinical suspicion based screening provides a relatively under-utilized opportunity for detection of new cases, along with commonly used high risk perinatal screening.

  • Rising SPR in children reflects perhaps not only the higher prevalence in adult study population, but also more liberal screenings ordered by clinicians due to increased awareness.

  • In a resource poor setting, use of simpler WHO criteria for diagnosis of symptomatic HIV infection/AIDS appears more practical than stricter CDC criteria, especially in younger children.

 

 References
  1. Bhakoo ON, Shenoi A. HIV infection in pediatric age group. Indian Pediatr 1990, 27: 891-898.

  2. Indian Council of Medical Research. Children with HIV/AIDS: Challenges and Opportuni-ties. ICMR Bull 1997; 27: 117-127.

  3. Indian Council of Medical Research. Turning point in HIV/AIDS research: Vision of hope. ICMR Bull 1996; 26: 123-132.

  4. Salunke SR, Shaukat M, Hira SK, Jagtap MR. HIV/AIDS in India: A country responds to a challenge. AIDS Update 1998; 3: 1-2.

  5. World Health Organization. Acquired immu-nodeficiency syndrome (AIDS) - WHO/CDC case definition for AIDS. Wkly Epidemiol Rec 1986, 10: 72-73.

  6. World Health Organization. Global program on AIDS: Recommendations for the selection and use of HIV antibody test. Wkly Epidemiol Rec 1992; 20: 145-149.

  7. World Health Organization. Guidelines for the Clinical Management of HIV Infection in Children. Geneva, World Health Organiza-tion, 1993; pp 1.2-1.3.

  8. Centre for Disease Control. 1994 Revised Classification System for Human Immuno-deficiency Virus infection in children less than 13 years of age. MMWR 1994; 43: 1-10.

  9. Emodi IJ, Ikafor GO. Clinical manifestations of HIV infection in children at Enugu, Nigeria. J Trop Pediatr 1998; 44: 73-76.

  10. Merchant RM, Shroff RC. HIV sero-prevalence in disseminated tuberculosis and chronic diarrhea. Indian Pediatr 1998; 35: 883-887.

Home

Past Issue

About IP

About IAP

Feedback

Links

 Author Info.

  Subscription